Linkage between the distribution of mutations in the CYP2C18 and CYP2C19 genes in the Japanese and Caucasian

References

• DE MORAIS, S. M. F., WILKINSON, G. R., BLAISDELL, J., MEYER, U. A., NAKAMURA, K. and GOLDSTEIN, J. A., 1994a, Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Molecular Pharmacology, 46, 594–598.
   Google Scholar
• DE MORAIS, S. M. F., WILKINSON, G. R., BLAISDELL, J., NAKAMURA, K., MEYER, U. A. and GOLDSTEIN, J. A., 1994b, The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. Journal of Biological Chemistry, 269, 15419–15422.
   Google Scholar
• FURUYA, H., MEYER, U. A., GELBOIN, H. V. and GONZALEZ, F. J., 1991, Polymerase chain reaction-directed identification, cloning, and quantification of human CYP2C18 mRNA. Molecular Pharmacology, 40, 375–382.
   PubMed Web of Science ®Google Scholar
• GED, C. and BEAUNE, P., 1992, Partial sequence and polymerase chain reaction-mediated analysis of expression of the human CYP2C18 gene. Pharmacogenetics, 2, 109–115.
   PubMedGoogle Scholar
• GOLDSTEIN, J. A. and DE MORAIS, S. M. F., 1994, Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics, 4, 285–299.
   PubMedGoogle Scholar
• GONZALEZ, F. J., 1989, The molecular biology of cytochrome P450s. Pharmacological Reviews, 40, 243–288.
   Web of Science ®Google Scholar
• GUENGERICH, F. P. and SHIMADA, T., 1991, Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chemical Research in Toxicology, 4, 391–407.
   PubMed Web of Science ®Google Scholar
• IBEANCT, G. C. and GOLDSTEIN, J. A., 1995, Transcriptional regulation of human CYP2C genes: functional comparison of CYP2C9 and CYP2C18 promoter regions. Biochemistry, 34, 8028–8036.
   PubMedGoogle Scholar
• INOUE, K., INAZAWA, J., SUZUKI, Y., SHEVIADA, T., YAMAZAKI, H., GUENGERICH, F. P. and ABE, T., 1994, Fluorescence in situ hybridization analysis of chromosomal localization of three human cytochrome P450 2C genes (CYP2C8, 2C9, and 2C10) at 10q24.1. Japanese Journal of Human Genetics, 39, 337–343.
   PubMedGoogle Scholar
• INOUE, K., YAMAZAKI, H., ImIYA, K., AKASAKA, S., GUENGERICH, F. P. and SHIMADA, T., 1997, Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4'-hydroxylation activities in livers of Japanese and Caucasian populations. Pharmacogenetics, 7, 103–113.
   PubMedGoogle Scholar
• KOMAI, K., SUMIDA, K., KANEKO, H. and NAKATSUKA I., 1996, Identification of a new non-functional CYP2C18 allele in Japanese: substitution of T204 to A in exon2 generates a premature stop codon. Pharmacogenetics, 6, 117–119.
   Google Scholar
• MEEHAN, R. R., GOSDEN, J. R., ROUT, D., HASTIE, N. D., FRIEDBERG, T., ADESNIK, M., BUCKLAND, R., HEYNINGEN, V. V., FLETCHER, J., SPURR, N. K., SWEENEY, J. and WOLF, C. R., 1988, Human cytochrome P-450 PB-1: A multigene family involved in mephenytoin and steroid oxidations that maps to chromosome 10. American Journal of Human Genetics, 42, 26–37.
   PubMed Web of Science ®Google Scholar
• NEBERT, D. W. AND GONZALEZ, F. J., 1987, P450 genes: structure, evolution, and regulation. Annual Reviews of Biochemistry, 56, 945–993.
   PubMed Web of Science ®Google Scholar
• NELSON, D. R., KOYMANS, L., KAMATAKI, T., STEGEMAN J. J., FEYEREISEN, R., WAXMAN, D. J., WATERMAN, M. R., GOTOH, O., COON, M. J., FSTABROOK, R. W., GUNSALUS I. C. and NEBERT D. W., 1996, P450 superfamily : update on new sequences, gene mapping, accession numbers and nomenclature. Phamaco genetics, 6, 1–42.
   Google Scholar
• RICHARDSON, T. H., GRIFFIN, K. J., JUNG, F. J., RAUCY, J. L. and JOHNSON, E. F., 1997, Targeted antipeptide antibodies to cytochrome P450 2C18 based on epitope mapping of an inhibitory monoclonal antibody to P450 2C5. Archives of Biochemistry and Biophysics, 338, 157–164.
   PubMedGoogle Scholar
• ROMKES M., FALETTO, M. B., BLAISDELL, J. A., RAUCY, J. L. and GOLDSTEIN, J. A., 1991, Cloning and expression of complementary DNAs for multiple members of the human cytochrome P4501IC subfamily. Biochemistry, 30, 3247–3255.
   Google Scholar
• SHIMADA, T., MISONO, K. S. and GUENGERICH, F. P., 1986, Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. Journal of Biological Chemistry, 261, 909–921.
   PubMed Web of Science ®Google Scholar
• SHIMADA T., YAMAZAKI, H., MIMURA M., INUI, Y. and GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414–423.
   Google Scholar
• TSUNEOKA, Y., MATSUO, Y., OKUYAMA, E., WATANABE, Y. and ICHIKAWA, Y., 1996, Genetic analysis of the cytochrome P-450I1C18 (CYP2C18) gene and a novel member of the CYP2C subfamily. FEBS Letters, 384, 281–284.
   PubMed Web of Science ®Google Scholar
• WANG, S. L., HUANG, J. D., LAI, M. D. and TSAI, J. J., 1995, Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese. Pharmaco genetics, 5, 37–42.
   PubMedGoogle Scholar
• YAMAZAKI, H., INouE, K., TURVY, C. G., GUENGERICH, F. P. and SHIMADA, T., 1997, Effects of freezing, thawing, and storage of human liver samples on the microsomal contents and activities of cytochrome P450 enzymes. Drug Metabolism and Disposition, 25, 168–174.
   PubMed Web of Science ®Google Scholar
• ZAPHIROPOULOS, P. G., 1997, Exon skipping and circular RNA formation in transcripts of the human cytochrome P450 2C18 gene in epidermis and of the rat androgen binding protein gene in testis. Molecular and Cellular Biology, 17, 2985–2993.
   PubMed Web of Science ®Google Scholar